prime DX

prime DX


The prime DX new technology for tumor molecular profiling is compatible with both FFPE and PLASMA.

Prime DX is designed to give to the physician an overall outlook on treatment response for:
• Targeted therapy
• Immunotherapy
• Chemotherapy

Learn more
HerediGENE

HerediGENE


HerediGENE is a test that fully analyzes a panel of genes, including BRCA1 and BRCA2, which are responsible for increased risk of developing breast, ovarian and other hereditary cancers.

Learn more
OncotypeDX<sup>®</sup><br /> Breast

OncotypeDX®
Breast


The OncotypeDX® breast cancer test is a diagnostic test created to help patients who have been recently diagnosed with early stage, estrogen receptor positive breast cancer.

Learn more
Com.Pl.i.t. DX<br/> Assay

Com.Pl.i.t. DX
Assay


Com.Pl.i.t. DX Assay is a multigene test designed to help you and your physician make informed treatment decisions based on the unique biology of your tumor and individualize your treatment.

Learn more
cloud
cloud

Services

Molecular Genetics

Genekor is specialized in molecular genetics.

Utilizing cutting edge technology, our company offers all the validated molecular tools for the diagnosis, prognosis and individualized treatment.

cloud
cloud

Services

Oncology, Cardiology, Neurology and Pharmacogenetics

We focus on oncology, cardiology, neurology and pharmacogenomics. Our goal is to achieve the most direct, most valid and most economical diagnostic procedure in order to generally improve patient care.

Company

Genekor

GeneKor is multinational molecular diagnostics company founded in 2007 and operates molecular biology laboratories with state of the art equipment suitable to provide the highest quality of Molecular Services . We provide a diversification of services focused on improving patient care utilizing the latest technologies of prognostic, predictive, and personalized medicine.

The clinical expertise of GeneKor focuses on:

  • Response to Targeted Therapy
  • Pharmacogenetics
  • Determination of Hereditary Cancer (Breast Cancer , Colon Cancer , Thyroid Cancer , Pancreatic Cancer , etc.)
  • New Unique Technological Platforms (OncotypeDX BreastTM, OncotypeDX ColonTM, OncotypeDX ProstateTM, PCA3TM)
Change cookies consent Revoke cookies consent